PsyPal, the first consortium to receive an EU clinical research grant for the study of psychedelic therapy, has published a comprehensive guidance paper to inform stakeholders across research, clinical practice, regulation, policy, advocacy, and industry. The paper outlines key considerations…
The 12th EPA Forum took place on Saturday, 28 March in Prague ahead of the 34th European Congress of Psychiatry. The event brought together perspectives from psychiatry, psychology, neurology, lived experience, informal caregivers, and health policy from the UN, EU,…
EPA Past-President, Prof Geert Dom, spoke at the European Parliament in Brussels on 18 March 2026. The event “European Vision for the Brain: Coordinating Research, Care & Innovation” took place as part of Brain Health Week, thanks to the European Brain Council…
EPA President, Prof. Andrea Fiorillo, spoke at the Brain Health Summit in Brussels on 18 March 2026. The Brain Health Summit was once again organised by the Brain Health Mission and our partners, the European Academy of Neurology (EAN), the…
The EPA is pleased to announce that it has joined the Sleep Health Europe Coalition. The Coalition gathers voices and associations from across sleep science, healthcare, advocacy, and civil society. The EPA is proud to represent the psychiatry community as part…
The Parliamentary Assembly of the Council of Europe (PACE) has unanimously adopted an opinion opposing the draft additional protocol on involuntary placement and treatment in mental healthcare services to the Convention on Human Rights and Biomedicine (Oviedo Convention) on 28…
The EPA welcomes the recent vote by the Parliamentary Assembly of the Council of Europe (PACE) calling on European countries to adopt legislation prohibiting conversion practices. Adopted by a clear majority during the Assembly’s plenary session in Strasbourg, the resolution…
The European Parliament’s Committee on Women’s Rights and Gender Equality (FEMM) and Committee on Public Health (SANT) have held a joint Hearing on “Digital violence and women’s mental health”, on Thursday, 11 December 2025. The hearing featured a presentation by…
Prof. Andrea Fiorillo, EPA President, and Prof. Celso Arango, EPA President Elect presented the latest edition of the Headway – Mental Health Index 5.0 on “Care, Cohesion, and Growth: Advancing Mental Health through the Wellbeing Economy” at the European Parliament…
Fantastic news! PsyPal has reached a major milestone with the inclusion of its first patient in the multi-site clinical trial investigating psilocybin therapy for psychological and existential distress in people with progressive, life-limiting illnesses. The EPA is proud to be…